Announce Date | 08/06/2025 |
EPS Normalized Actual | $-0.1 (Beat by $0.04) |
EPS GAAP Actual | $-0.1 (Beat by $0.04) |
Revenue Actual | $7.0588E-5B |
Revenue Surprise | Beat by $0.070588M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0 |
EPS GAAP Estimate | $0 |
Revenue Estimate | $0.00021B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | -0.31 | -4.87 | -0.31 | -0.31 | 1 |
Dec 2025 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.1 | -0.1 | 7.0588E-5B | 61.98% | 0.04M |
FQ1 2025 (Mar 2025) | -0.15 | -0.15 | 4.1015E-5B | -91.81% | 0.01M |
FQ4 2024 (Dec 2024) | 0 | -1.54141 | 2.7179E-5B | 24.44% | -0.05M |
FQ3 2024 (Sep 2024) | -0.23 | -1.57259 | 3.6031E-5B | 33.08% | -0.04M |
FQ2 2024 (Jun 2024) | -0.17 | -1.51259 | 2.684E-5B | 100% | -0.04M |
FQ1 2020 (Mar 2020) | -0.0166 | -0.0166 | 8.6753E-5B | 100% | 0.09M |
FQ2 2020 (Jun 2020) | -0.0166 | -0.0166 | 8.6752E-5B | 100% | 0.09M |
FQ3 2020 (Sep 2020) | -0.22 | -0.22 | 3.6905E-5B | 100% | 0.04M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.00021B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | -0.09 | -- | -0.09 | -0.09 | 1 |
FQ3 2026 (Sep 2026) | -0.09 | -- | -0.09 | -0.09 | 1 |
FQ2 2026 (Jun 2026) | -0.1 | 0 | -0.1 | -0.1 | 1 |
FQ1 2026 (Mar 2026) | -0.12 | -25 | -0.12 | -0.12 | 1 |
FQ4 2025 (Dec 2025) | 0 | -- | 0 | 0 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 1 |
FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 1 |
FQ2 2026 (Jun 2026) | 0B | 49.58 | 0B | 0B | 1 |
FQ1 2026 (Mar 2026) | 0B | 58.99 | 0B | 0B | 1 |
FQ4 2025 (Dec 2025) | 0B | 87.06 | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | -0.1 | -0.1 | 100% |
FQ1 2025 (Mar 2025) | 0 | -0.15 | -0.15 | 100% |
FQ4 2024 (Dec 2024) | 1.54141 | 0 | -1.54141 | -INF% |
FQ3 2024 (Sep 2024) | 1.34259 | -0.23 | -1.57259 | 683.73% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.17 | -1.51259 | 889.76% |
FQ1 2020 (Mar 2020) | -0.0166 | -0.0166 | 100% | |
FQ2 2020 (Jun 2020) | -0.0166 | -0.0166 | 100% | |
FQ3 2020 (Sep 2020) | -0.22 | -0.22 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0B | $0.04M | 50.42% |
FQ1 2025 (Mar 2025) | $0B | $0B | $0.01M | 14.67% |
FQ4 2024 (Dec 2024) | $0B | $0B | $-0.05M | -183.91% |
FQ3 2024 (Sep 2024) | $0B | $0B | $-0.04M | -116.24% |
FQ2 2024 (Jun 2024) | $0B | $0B | $-0.04M | -164.83% |
FQ1 2020 (Mar 2020) | $0B | $0B | $0.09M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0B | $0.09M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0B | $0.04M | 100% |